Pregnancy disorders

Published on 02/03/2015 by admin

Filed under Internal Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1394 times

Chapter 32 Pregnancy disorders

Introduction

Pregnancy is a special time in a woman’s life that should be enjoyed with good health. Due to a surge of hormones and rapid physical changes by the body, a number of distressing symptoms may arise, especially if the woman is unprepared. Many women conceive without planning a pregnancy, so it is not always possible to be prepared for a pregnancy. Hence it is vital that women optimise their health as soon as they make the decision to plan a pregnancy.

Complementary and alternative medicines (CAMs) are frequently used in pregnancy, more than prescription medicines, according to Australian research.1 These CAMs include massage (49%), vitamin and mineral supplements (30%) and yoga (18.4%) which are not likely to be harmful in pregnancy. The study highlighted more than three-quarters had used at least 1 complementary therapy 8 weeks prior to the study; one-third had used complementary medicine to alleviate a physical symptom such as headache, cough or cold with a 95% positive response to treatment compared with 6.8% of women on prescription medicine to treat a complaint.

Studies in the Netherlands found up to 36% of women were using herbs in pregnancy and up to 43% during breastfeeding.2 The most commonly used herbs in pregnancy include red raspberry leaf, ginger, chamomile3 and also echinacea and cranberry.2 Less commonly used supplements were fish oil, herbal teas, blue cohosh, acidophilus, ombeshi plums, homeopathic drops, peppermint and St John’s wort.

Mind–body medicine

Psychosocial and psychological factors

Many women experience anxiety during pregnancy and fear of pain, especially with a vaginal delivery. Studies suggest that personality factors such as general anxiety, neuroticism, low self-esteem and vulnerability, and dissatisfaction with their partners, violence in the relationship, lack of social support and unemployment will contribute and amplify pregnancy related anxiety.6, 7 Strategies such as increasing supports, meditation, counselling and cognitive behaviour therapy (CBT) should be aimed at reducing maternal anxiety and addressing issues with the partner. Even a telephone-based peer support line can make a significant difference in preventing postnatal depression among women at high risk.8

Environmental factors

Alcohol

The Australian new-draft alcohol guidelines state that for pregnant women and women planning pregnancy no drinking is the safest option.16 A British study examining the effects of low–moderate prenatal alcohol exposure on pregnancy outcome found no convincing evidence of adverse effects.17 Similar findings have been found by a Western Australian group, however, alcohol intake at higher levels, particularly heavy and binge drinking patterns, was associated with increased risk of pre-term birth even when drinking was ceased before the 2nd trimester.18 Adverse effects of alcohol exposure on the fetus include fetal alcohol syndrome (1–3 % of live births), birth defects, neurodevelopmental disorders, miscarriage, still births, pre-term births and low birth weight.

Fetal alcohol exposure can be minimised through abstaining or reducing alcohol consumption or increasing effective contraception in females who engage in risk drinking.19

Animal studies suggest dietary zinc supplementation may play a role in preventing fetal alcohol syndrome due to prenatal ethanol exposure, although more studies are required.20

Nutritional influences

Diet

A number of studies have evaluated the role of diet in the prevention of gestational diabetes and pre-eclampsia. It is essential women maintain a healthy diet as nutritional needs are increased substantially during this time. Substantial epidemiological evidence documents diverse health benefits associated with diets high in fibre, fish and low in glycaemic index (GI).

Western diet

Maternal consumption of the Western diet (e.g. high in meat, pizza, legumes, and potatoes, and low in fruits) increases the risk of offspring with a cleft lip and/or cleft palate by approximately twofold.29 The authors postulated low folate levels in the Western diet may account for this association and, therefore, recommend dietary and lifestyle profiles should be included in preconception screening programs.

Fish and heavy metal exposure in pregnancy

Fish is an important part of dietary intake. It contains a number of essential nutrients such as eicosopentaenoic acid (EPA) and docosohexaenoic acid (DHA), important for development of the fetal brain and retina, and is rich in iodine, iron, choline, selenium, and trace elements important for pregnancy and fetal growth. Also meta-analysis of the literature indicates maternal diet high in fish may reduce the risk of inflammatory conditions such as rheumatoid arthritis, atopy and asthma in the newborn, although more evidence is required.30, 31

Health benefits of fish may counterbalance any adverse effects of mercury exposure on the developing nervous system.32 All fish contains some mercury in their flesh, mostly in the form of organic methyl mercury (MeHg), a known neurotoxin which can cause developmental delay, neurological problems and damage to the developing central nervous system (CNS). The quantity of MeHg present in fish varies depending on the dietary habits and age of the fish, and is particularly concentrated in the larger predatory fish at the top of the food chain.

Foods Standards Australia New Zealand (FSANZ) has useful advice on mercury in fish.33 FSANZ found that most fish is safe for all population groups to eat 2–3 serves per week and recommends that pregnant women, women planning pregnancy and young children continue to consume a variety of fish as part of a healthy diet, but limit their consumption of the larger predatory fish such as shark, marlin, broadbill and swordfish (containing highest levels of MeHg) to no more than 1 serve per fortnight with no other fish to be consumed during that fortnight. For orange roughy (also sold as sea perch) and catfish, the FSANZ advice is to consume no more than 1 serve per week, with no other fish being consumed during that week.33

The FSANZ ‘Advice on Fish Consumption’ has been specifically developed for the Australian population and suggests that women in other countries check with their local authorities as mercury content of fish varies from country to country depending on the environmental exposure, patterns of fish consumption in the community and other food sources consumed containing mercury.

Nutritional risk factors in pregnancy

Recommended daily intakes (RDIs) are increased significantly during pregnancy and lactation due to extra demands by the pregnant mother and infant. The diet of the mother is of great importance to the fetus. Dietary guidelines are similar to those given to the general public with special attention to foods that provide good sources of iodine, calcium, iron, folate and dietary fibre.

The increased needs during pregnancy can vary from 12% for dietary fibre, 14% for vitamin A, 46% for vitamin B6, 50% for folate, 37% for zinc, 50% for iron, 46% for iodine, 30% for protein and 25% for essential fatty acids.34, 35

Teenage pregnancy requires special needs as a mother’s body is still growing in many instances. The ideal weight gain for teenage pregnancy is 10kg; lower weight gain can lead to lower birth weight which can be associated with greater risk of developing type 2 diabetes and hypertension later in life, as well as a weight problem.27

Routine supplementation with iron, vitamin A, C and E are not recommended in pregnancy. 36

Vegetarian mothers are at risk of deficiencies in protein, iron, vitamin B12, folate, calcium and zinc and should be screened early in pregnancy, if not beforehand, to minimise complications. Untreated vitamin B12 deficiency may lead to serious neurological consequences especially in exclusively breastfed babies. Vegan sources of omega-3 foods include soybeans, beans, linseed, walnuts, pecans and soy.

Vitamin D deficiency is common in dark skinned, veiled women and their breastfed offspring should also be screened with consideration to supplement with vitamin D.

Nutritional supplements

Fish oil for pregnancy and breastfeeding

Fish oils play an important role in pregnancy and in the development of the fetus and newborn. Pregnant women should be encouraged to eat at least 3 deep sea fish a week although there are real concerns with heavy metal toxicity in the larger predator fish (see section titled ‘Fish and heavy metals’).37 A number of studies demonstrate fish oils can significantly reduce the risk of atopy, asthma (see Chapter 5 for asthma information) and other immune-mediated diseases by positively modulating inflammation and prostaglandin effects on the newborn child. In addition, the benefits of fish oils are carried through to breastfed babies. In bottle-fed babies, the benefits are through formulas enriched with fish oils.3842

For instance, a population-based study of 533 pregnant women from 30 weeks gestation to birth were randomly assigned to receive 4 x 1g gelatin capsules/day of fish oil (2.7g n-3 PUFAs) or 4 x 1g similar-looking capsules/day with olive oil, or no oil capsules.43 Over a 16-year follow-up of offspring, the risk of asthma was reduced by 63% and of allergic asthma by 87% in those pregnancies treated with fish oil compared with the olive oil group. This study supports a potential prophylactic role of fish oils late in pregnancy, reducing risk of asthma in the newborn.43

Women consuming fish oil supplements compared with olive oil capsules were also less likely to experience pre-term delivery and more likely to reach full term without any complications.44 The high intake of fish oils might prolong pregnancy by shifting the balance of production of prostaglandins in parturition.

Fish oils play an important role in the development of the nervous system and augments cognitive function, IQ, vision and behaviour in offspring to mothers supplemented with fish oils during pregnancy and breastfeeding.4560

However, a double-blind study randomised pregnant mothers to take 10ml of either cod-liver oil or corn oil from 18 weeks gestation until 3 months after delivery.61 At 7 years of age, children were assessed and the researchers found higher maternal plasma phospholipid concentrations of alpha-linolenic acid (18:3n-3) and docosahexaenoic acid during pregnancy were correlated with enhanced cognitive function, such as sequential processing, but no significant effect was observed on global IQs or on BMI in the children.

Multi-nutrients and pregnancy

Micronutrients such as vitamins and minerals are necessary for the growing demands experienced by the pregnant mother and for the normal functioning, growth and development of the fetus. A Cochrane review of 9 trials including 15 378 women demonstrated multi-nutrient supplementation reduced the number of low birth weight and small-for-gestational-age babies and maternal anaemia, but close analyses of the data revealed no added benefit compared with iron/folic acid supplementation alone.62 Further research is required to confirm the benefits of taking multi-nutrients during pregnancy.

A systematic review and meta-analysis of the use of prenatal supplementation with multivitamins found that they decreased the risk for paediatric brain tumour, neuroblastoma and leukaemia.63

Vitamin A deficiency

Vitamin A deficiency is common in developing countries such as Indonesia and Nepal due to poor nutritional intake where daily or weekly supplementation may be necessary as deficiency of vitamin A causes night-blindness, anaemia and other problems.64 However, in women with adequate nutritional intake, vitamin A supplementation can cause toxicity, especially doses >10 000IU/day, and should be avoided. Toxic levels can cause miscarriage and birth defects. Note: beta-carotene intake is very safe.

Vitamin C deficiency

It is not clear if taking vitamin C supplementation in pregnancy is safe, because a Cochrane review found in a trial that vitamin C supplementation was linked with a moderate risk of pre-term birth, although more studies are required to confirm this adverse effect.65 Vitamin C deficiency is linked with complications in pregnancy such as pre-eclampsia, anaemia and intrauterine growth retardation, and so women should be encouraged to eat foods rich in vitamin C such as fruit.

Vitamin D deficiency

Severe vitamin D deficiency can cause maternal osteomalacia and lead to significant morbidity in the mother and fetus. The prevalence of vitamin D deficiency in pregnant women is high and this can have serious health ramifications in the mother and child.66, 67 Pregnant women who are deficient in vitamin D can lead to reduced weight gain and pelvic deformities that prevent normal delivery. For the fetus, vitamin D deficiency is linked with poor fetal growth, low birth weight, neonatal hypocalcemia with and without convulsions, neonatal rickets, defective tooth enamel, and pre-disposition to childhood rickets, particularly in breastfed, dark skinned children.68, 69, 70 Deficiency is common in populations residing in geographically prone areas such as southern Australia (e.g. Melbourne) and in some high-risk communities such as migrants, women wearing veiled clothing, and people who spend more time indoors.71 Ninety percent of the body’s vitamin D is produced by the skin from sunlight (ultraviolet B light) exposure of non-covered skin without sunscreen, with only 10% coming from dietary sources. It is essential to restore vitamin D deficiency in mothers by advising safe sun exposure which is dependent on geographical areas and pigmentation of the skin (the darker the skin the more sun that is required), and supplement with cholecalciferol if needed, but this needs to be done cautiously to avoid vitamin D toxicity. Excessive vitamin D may cause hypercalcemia and fetal harm. Doses within RDI are safe. According to a Cochrane review of the literature, there is not enough evidence to date to evaluate the effects of vitamin D supplementation in pregnancy.72 Vitamin D is excreted in milk in limited amounts, and with excessive use can cause toxicity in infants. If pharmacological supplementation is required, it is essential to monitor calcium levels in the infant and get maternal vitamin D checked regularly.

Folate deficiency

Folate is one of the most important nutrients for healthy fetal development. Pregnant women and the growing embryo require higher levels of folate for cell replication and growth. Rapidly dividing cells in the embryo fail to produce healthy DNA if folate levels are low. The recommended daily intake for folate is increased significantly by 50% in pregnancy. It is recommended that every woman planning a pregnancy should take 500mcg folate a few months prior to pregnancy and in the 1st trimester although recent studies indicate that folate supplementation in the 2nd trimester may help prevent pre-eclampsia.73 Low folate levels are associated with increased risk of spontaneous abortion, anaemia, low birth weight and congenital malformations such as neural tube defects (NTD), oral clefts and cleft palate, and cardiovascular and urinary tract malformations.74, 75 Overall, nutritional deficiency in the pregnant woman (not just folate deficiency) can increase the risk of orofacial cleft. Increasing intakes of vegetables, protein, fibre, fruit, ascorbic acid, iron, vitamin Bs and magnesium also reduce the risk of orofacial cleft.76, 77

Folate is essential for fetal brain and spinal cord development. A Cochrane review evaluated 4 trials of folate supplementation involving 6425 women. Peri-conceptional folate supplementation significantly reduced the incidence of NTD (relative risk 0.28, 95% confidence interval 0.13 to 0.58) without significant harmful effects such as miscarriage, ectopic pregnancy or stillbirth. The authors also found multivitamins were not associated with any additional beneficial preventative effects of NTDs even when given with folate.78

Minerals

Iron deficiency

The recommended daily intake for iron is increased significantly, by 50%, in pregnancy. Iron deficiency is linked with infertility, anaemia, increased risk of infection, fatigue, and behavioural and cognitive development problems.84, 85, 86 It is possible that fetal oxygenation is compromised with iron deficiency.85 While the benefits are clear for iron supplementation, if the mother demonstrates serum iron deficiency with or without anaemia, at this stage, there is not enough evidence to recommend routine iron supplementation in all pregnant women.87

Medical conditions associated with pregnancy or a complication of pregnancy

Gestational diabetes mellitus (GDM)

Between 1 to 14% of women develop GDM during pregnancy. Dietary advice is essential to help reduce the incidence of diabetes in pregnancy and subsequently in life. GDM can cause significant health problems, such as a very large baby, and increase the risk of negative and adverse pregnancy outcomes, such as an increased risk of induced birth and caesarean section, prematurity and increased infant morbidity and mortality. GDM is also associated with an increased risk of diabetes for mother and child later in life.

Low GI diet and GDM

A low GI diet can effectively halve the need to use insulin compared with a high GI diet, according to a recent randomised study.99

A Cochrane review identified 3 trials including 107 women.100 Two trials assessed low versus high GI diets for pregnant women. Women on low GI diets, had less large-for-gestational-age infants and lower maternal fasting glucose levels. The other trial assessed high fibre versus control diet but the trial did not report on the outcomes. The reviewers concluded based on these findings that whilst ‘a low glycaemic index diet was seen to be beneficial for some outcomes for both mother and child, results from the review were inconclusive’.100

Pre-eclampsia (PE)

PE is a serious condition affecting pregnant women and occurs in about 2–8% of women, characterised by high blood pressure, with or without proteinuria.

Exploring diet and lifestyle are essential to lower the risk of developing PE, particularly increasing nutrient rich foods for antioxidants, vitamin E, calcium and magnesium as deficiency of these nutrients can predispose to PE. This is commonly seen in under-nourished, low socio-economic communities. A diet high in sugar and fat, cigarette smoking and low physical activity are known risk factors for PE. Stress is a contributor to PE-like hypertension. It is likely other lifestyle risk factors may also play a role in PE and strategies such as stress management, dietary changes (increasing vegetables, high fish intake), exercise and sleep restoration should assist in the management of PE (see Chapter 19 on hypertension). Calcium and magnesium appear to be particularly effective and may play an important role as therapeutic agents for PE. PE can cause serious morbidity and can lead to death in pregnant women, who should be monitored closely, including for onset and progression of chronic kidney disease.102

Stress and PE

Work stress is a significant predictor and risk factor for developing PE.103 In a trial on pregnant normotensive women, heart rate increased and mean arterial blood pressure rose by more than 2.9mmHg, and in some up to 10mmHg on work days.104 Higher blood pressures occurred in women experiencing greater job stress.

Antioxidants and PE

Findings from a Cochrane review could not recommend the use of antioxidants for the prevention of PE107 although another Cochrane review found women taking vitamin supplements ‘may be less likely to develop pre-eclampsia and more likely to have a multiple pregnancy’.108

Vitamins C and E and PE

Inadequate dietary intake of vitamin E during pregnancy is associated with PE and low birth weight. A Cochrane review found in trials that pregnant women supplemented with vitamin E in combination with other supplements compared with placebo were at reduced risk of developing clinical PE, however, the data was too few to recommend supplementation in pregnancy at this stage.109

One double-blind RCT of 283 women at risk of PE (previous history of PE or placental blood flow abnormalities) were assigned to 1000mg/day of vitamin C and 400IU/day of vitamin E or placebo at 16-22 weeks gestation.110 Vitamin supplementation correlated with a significant 21% reduction in plasma markers reflecting endothelial and placental function. Plasma ascorbic acid increased 32% on average, and the α-tocopherol level increased by 54%. PE developed in 17% of placebo recipients but in only 8% of women given vitamins. Furthermore, small-for-gestational-age infants were less frequent, although less significant in the vitamin-supplemented group. Subsequent research demonstrated similar findings.111, 112

Another study found 1000mg of vitamin C or 400IU of vitamin E did not reduce the risk of PE compared with placebo, however, the synthetic form of vitamin E was used in this study.113 Women should be encouraged to eat foods high in vitamin E found in vegetable oils, nuts, cereals and some leafy green vegetables.

However, a recent study warns against peri-conception use of vitamin E supplements with high dietary vitamin E intake above 14.9mg/day as it increased the risk of congenital heart defects (CHDs) in offspring by nine fold.114

Hyperemesis gravidarum (HG)

Nausea and vomiting

Nausea and vomiting may occur in the early stages of pregnancy and can be quite intense and disabling for the mother. In some mothers, nausea and vomiting persist throughout the whole pregnancy. HG occurs in 0.5–2% of pregnant women, although up to 85% of women will experience some level of nausea. When symptoms are severe, some women require hospitalisation and intravenous fluid therapy to avoid dehydration.

Many trials have compared the use of vitamin B6 and ginger with anti-emetic medication. A Cochrane review of the literature found anti-emetic medication to reduce the frequency of nausea but there is little research that explores adverse fetal outcome from this medication and it can cause side-effects such as drowsiness in the mother. The reviewers found evidence for ginger, acupressure (of pericardium P6) and vitamin B6 in reducing severity of nausea and vomiting.122

Ginger (zingiber officinale) and nausea

Ginger is a popular remedy used by pregnant women for the treatment of nausea in pregnancy. A Cochrane review of 6 RCTs involving 675 pregnant women assessed the evidence for efficacy and safety of ginger therapy for nausea and vomiting in early pregnancy.127 The authors concluded that ginger may be an effective treatment choice for nausea and vomiting associated with early pregnancy but further studies with larger numbers of women are required to confirm the promising preliminary data for the safety of this therapy. Four of the 6 RCTs showed superiority of ginger over placebo and 2 of them showed equivalence to vitamin B6 in relieving the severity and episodes of nausea and vomiting.128

Cramps

Calcium and magnesium can provide effective treatment for pregnancy-induced leg cramps.131, 132, 133

(Source: Maconochie N, Doyle P, Prior S, Simmons R. Risk factors for first trimester miscarriage — results from a UK-population-based case-control study. BJOG 2007;114(2))

Nutritional factors and miscarriage

A Cochrane review of the literature found research to date indicates that pregnant women taking a daily multivitamin supplementation prior to or early in pregnancy does not reduce the risk of miscarriage or stillbirth.137 It is likely that supplements used did not contain enough of the nutrients that can be protective. The quality of the nutrients is also important. The amount of nutrients and the type of nutrient, especially whether they were synthetic or natural, may have been an important factor in this study, which could explain this unexpected result.

Despite these findings, numerous studies have demonstrated the association between increased homocysteine and spontaneous miscarriage.138, 139 Folic acid and vitamin B6 and B12 take part in the metabolism of homocysteine.

Coeliac disease is associated with damaged intestinal mucosa leading to a malnourished state caused by the malabsorption of macro and micronutrients. Miscarriages are more frequently observed in those with coeliac disease.140 Therefore coeliac disease must be considered in the pre-conceptional screening and treatment of patients with reproductive disorders.

Iodine deficiency is a risk factor for growth and development of up to 800 million people living in iodine deficient environments throughout the world. The effects on growth and development, called the Iodine Deficiency Disorders, includes miscarriages.94, 95, 96 Poor diet or diets that are vitamin deficient such as folate have been associated with an increased risk of women losing their baby early in pregnancy.141

Pre-term birth, low birth weight, fetal failure to thrive

Depression, anxiety, stress and PTB

Depression and anxiety are risk factors for pre-term labour. Screening of pregnant women for depression may be useful as antenatal depression is significantly associated with almost twice the risk of pre-term delivery (before 37 weeks) compared with non-depressed women, according to a cohort study of 791 women assessed at 10 weeks gestation and followed up during pregnancy.147 Severe depression increased the risk by up to 2.2 times compared with women not suffering antenatal depression. The authors concluded that their findings show that pregnant women with depressive symptoms are a risk factor for PTB and exacerbated by stressful events, low educational level, and a history of fertility and obesity. It is likely excess cortisol produced in response to stress may play a role, although other factors may also contribute.

A study of 634 pregnant women revealed that depression was positively associated with underweight women (pre-pregnancy BMI below 19) and together with anxiety correlated with a higher incidence of pre-term delivery.148 Anxiety also correlated with vaginal bleeding. These findings indicate that depression and anxiety are associated with spontaneous pre-term labour.

Yoga reduces risk of PTB, PE, intrauterine growth retardation

A study demonstrated yoga consisting of gentle, daily physical postures, meditation and breathing improves pregnancy outcome, significantly reduces risk of PE, intrauterine growth retardation, pre-term labour and low birth weight newborns.149 No significant adverse events were reported in the yoga group. Yoga helps with relaxation, postural and stretching exercise so may have benefits in other areas of pregnancy, such as anxiety, headaches and back pain.

Diet and PTB

Caffeine effects and PTB

Studies consistently demonstrate the adverse effects of maternal caffeine consumption on fetal development.162165 A large prospective observational study of over 2600 low-risk pregnant women showed maternal consumption of caffeine from 100mg/day to over 300mg/day (1–3 cups/day) at any stage throughout the pregnancy was associated with a significant risk of fetal growth restriction.166 An intake of 200mg/day of caffeine was associated with a significant reduction of birth weight by 60–70g, and consumption of caffeine >100mg/day with each trimester led to drops in birth weight by 34–59g in the 1st trimester, 24–74g in the 2nd and 66–89g in the 3rd trimester. Caffeine is rapidly absorbed and crosses the placenta freely. Cytochrome P450 1A2, the principal enzyme involved in caffeine metabolism, is absent in the placenta and the fetus.

A recent study confirms these findings and demonstrated that the equivalent of only 1 dose of caffeine (just 2 cups of coffee) ingested during pregnancy may be enough to affect fetal heart development.167 The authors strongly advise pregnant women should not consume coffee.

Another study found that coffee consumption during pregnancy was associated with miscarriage, in particular if more than 3 cups of coffee were consumed per day.168

Magnesium protective for PTB

Magnesium is a promising nutrient not only for PE treatment but also in the prevention of pre-term labour and birth. An analysis of trials involving over 2600 pregnant women found oral magnesium treatment in early pregnancy was associated with reduced risk of pre-term birth, a lower frequency of low birth weight and less small-for-gestational age infants compared with placebo.170 Furthermore, the women treated with magnesium required less hospitalisation during pregnancy and less risk of antepartum haemorrhage compared with placebo treated women. However, the Cochrane review noted the poor quality trials are likely to have resulted in a biasness favouring magnesium supplementation and concluded at this stage that there is ‘not enough high quality evidence to show that dietary magnesium supplementation during pregnancy is beneficial’.170

A recent Cochrane review of 5 trials involving 6145 babies demonstrated giving intravenous magnesium sulfate to women at risk of pre-term birth significantly reduced the risk of cerebral palsy and the overall mortality of the infant.171 Side-effects included nausea, vomiting, headaches and palpitations. Epidemiological and scientific studies suggest that magnesium sulfate before birth may be neuroprotective for the fetus.

Premature rupture of membranes (PROM)

Pelvic and back pain in pregnancy

Back and pelvic pain are common symptoms of pregnancy aggravated by the weight of the growing newborn and then carrying after the baby is born. Management strategies include: exercise, rest, heat or cooling compresses, a supportive belt, using pillows during sleep and sitting, massage, acupuncture, chiropractic, relaxation, yoga and Reiki, and if necessary the use of medication such as paracetamol.

A Cochrane review was undertaken of 8 studies (1305 participants) that examined the effects of adding various pregnancy-specific exercises, physiotherapy, acupuncture and pillows to usual prenatal care.183 Women who were not instructed to do exercise, stretching or have acupuncture and just received usual prenatal care reported more use of analgesics, physical modalities and sacroiliac belts.

Labour and labour pain

Music and labour

Music plays an important role in the management of anxiety (see Chapter 4 on anxiety) and for pain relief. A systematic review of the literature identified 51 studies involving 3663 patients experiencing acute or chronic pain (not pregnant) and found music reduced pain by up to 50%, and reduced the need for morphine-like analgesics.187 It would appear calm, gentle, soothing music may play a role in helping reduce pain and anxiety during labour, as gentle music poses little risk or harm to the mother, although research is required to confirm this.

Yoga and labour

Practising regular yoga during pregnancy is associated with improved birth outcomes, improved maternal comfort and reduced labour pain.188191 Also, yoga practise was associated with higher incidence of vaginal birth rate and less need for caesarean section.

Labour pain

Perineal massage and labour

A Cochrane review of 3 good quality trials involving 2434 women comparing digital perineal massage with control demonstrated a clear benefit using perineal massage during pregnancy as little as once or twice weekly from 35 weeks gestation.199 Antenatal perineal massage significantly reduced the incidence of perineal trauma requiring suturing (episiotomy) especially in women without previous vaginal birth. In women with a history of previous vaginal birth they reported significant reduction of pain at 3 months post-partum.199 As such, women should be encouraged to undertake perineal massage, which can be done by the woman or her partner.

Perineal pain after labour

Cooling packs

Perineal tears following labour can cause much pain and discomfort for the mother and it is common practice after labour to apply ice or cold packs onto tears or cuts. 200 A review of the literature demonstrates that ice packs provide pain relief up to 72 hours following birth but women preferred gel pads (ease of use) when compared with ice packs or no treatment. There were no differences in level of bruising or oedema in each group.200

Antenatal and postnatal depression

Antenatal depression (AND) is common, affecting from 7.4% in the 1st trimester up to 12.8% in the 2nd trimester. Psychosocial and psychological support is vital for the wellbeing of the mother and child during and following pregnancy, especially for the prevention of post-partum depression.

A Cochrane review found too few trials to confidently make any recommendations for other therapies, such as massage therapy or depression-specific acupuncture, for the treatment of antenatal depression.202

Postnatal depression (PND) affects up to 15% of mothers. It is vital that PND is detected and treated early. Mothers require guidance and emotional and physical support, especially in the first few months following birth. It is a time when they experience poor sleep, may experience pain, illness, problems with lactation, have difficulty cooking, lack exercise and sunshine and all these factors can contribute to fatigue, exhaustion and depression. There is a traditional North American Indian saying: ‘it takes a whole village to bring up a child’. The level of support in smaller communities, extended families, villages and so forth, can play a vital role in supporting the mother, especially a first-time mother who needs guidance and assistance within the first year following birth. There are many cultures where women become more supportive to new mothers and provide assistance with cooking and cleaning.

A meta-analyses of the literature identified 9 studies (n = 956) that found psychosocial interventions such as peer support or non-directive counselling, cognitive behavioural therapy (CBT), interpersonal psychotherapy, and psychodynamic therapy significantly reduced evidence of depression within the first year after delivery, compared to usual care in women with PND.203 Professional counselling reduced rates of PND by 40%, while support from other mothers reduced the risk by up to 50%. Research consistently supports the value of psychological and psychosocial support in reducing the incidence of PND.204

Infants of mothers with PND are more likely to experience cognitive and psychomotor developmental delays, although the mechanism is not clear.205

Sleep and PND

Two-thirds of clinically significant depression symptoms in pregnancy occur in mothers reporting an infant with a sleep problem. An Australian study of mothers with infants 6–12 months of age found that sleep deprivation was a factor in PND.210 If the infant had a sleep problem, the mother was twice as likely to have PND. The same group showed that by improving the mother’s sleep, this improved the PND.211

In another study, this group is investigated for behavioural intervention for sleep problems on maternal depression.212 They concluded that sleep intervention in infancy resulted in sustained positive effects on maternal depression.

Fish oils and PND

It is well recognised that a diet high in fish and omega-3 supplementation may help with depression. (See Chapter 12 for more information on depression.) A small pilot study found omega-3 supplementation may help women with PND.213 A review of the literature found 3 trials of omega-3 fatty acids versus placebo for perinatal depression show conflicting results.214 It is likely women with lower levels of omega-3 fatty acids during pregnancy are more likely to develop depression than those with higher levels.

Herbal medicine

Conclusion

Pregnancy is a natural state and due to physical, emotional and hormonal changes throughout the pregnancy with the growth of the fetus, this can pose a number of different health challenges for the woman at any stage. Pregnancy for some women can cause a myriad of distressing symptoms. This chapter covers some of the common pregnancy-related complaints.

It is vital women are fit and healthy before entering pregnancy. For example, it is vital women eat well to maintain a healthy weight, avoid gestational diabetes and constipation, exercise regularly to help develop a good strong posture to support their back during the pregnancy, practise regular stress management strategies and increase their supports from friends and family for emotional wellbeing. A pregnancy multivitamin that contains 500mcg of folate taken once daily commenced at least 3 months ahead of a planned pregnancy can be useful for the prevention of a number of pregnancy-related diseases, such as neural tube defect. Consuming alcohol, smoking and drug intake should be avoided during the planning and pregnancy period. Pregnancies also occur unplanned, so efforts for good health and positive lifestyle and behavioural changes need to occur as soon as possible during the pregnancy.

This chapter has covered a whole range of conditions and health problems that may occur in pregnancy that can be treated or symptomatically managed using a range of evidence-based complementary medicines and therapies together with lifestyle changes, such as exercise, diet and stress management. Pregnancy itself is not a disease and so in this chapter (unlike other chapters) we have not prepared a table of evidence for lifestyle and complementary medicine/therapies in the management of pregnancy. Because we have covered a number of different disease and symptom states throughout the chapter, not just 1 or 2 diseases (as covered in other chapters), such a table might be quite confusing.

So, in summary, healthy lifestyle and behavioural changes before, during and after pregnancy can positively impact on the mother’s and child’s wellbeing.

Clinical tips handout for patients — pregnancy

5 Dietary changes

Avoid the following foods as they may contain the harmful bacteria Listeria, which can cause increased risk of miscarriage, stillbirth or premature labour in pregnancy, and is destroyed only with cooking:

Refer to the website for Foods Standards Australia New Zealand for more information:

http://www.foodstandards.gov.au/_srcfiles/Listeria.pdf

7 Supplements

Vitamins

Do not take vitamin A supplements as excessive intake of vitamin A above 3000IU/day can contribute to genetic problems in the baby.

Do not take vitamin E supplements in early pregnancy as it is linked to heart problems in the baby.

Minerals

References

1 Skouteris H., Wertheim E.H., Rallis S., et al. Use of complementary and alternative medicines by a sample of Australian women during pregnancy. ANZJ Obstet Gynecol. 2008;48:384-390.

2 Hedvig N., Gro C.H. Use of herbal drugs in pregnancy: a survey among 400 Norwegian women. Pharmacoepidemiology and Drug Safety. 2004;13:371-380.

3 Forster D.A., Denning A., Wills G. Herbal medicine use during pregnancy in a group of Australian women. BMC Pregnancy and Childbirth. 2006;6:21.

4 Murtagh J. General Practice.mcgraw–Hill, Australia, 4th Ed. ISBN: 0074717790 EAN: 9780074717790.

5 Lee K.A., Gay C.L. Sleep in late pregnancy predicts length of labour and type of delivery. Ame J Obstet Gynecol. 2004;191:2041-2046.

6 Saisto T., Salmela-Aro K., Nurmi J.E., et al. Psychosocial characteristics of women and their partners fearing vaginal childbirth. BJOGl. 2001;108:492-498.

7 HeatherRowe J., Maggie Kirkman, Annarella Hardiman E., et al. Considering abortion: a 12-month audit of records of women contacting a Pregnancy Advisory Service. MJA. 2009;190(2):69-72.

8 Dennis C.-L., Hodnett E., Reisman Heather M., et al. Effect of peer support on prevention of postnatal depression among high risk women: multisite randomised controlled trial. Published 15 January 2009, doi:10.1136/bmj.a3064 Cite this as: BMJ. 2009;338:a3064.

9 Smith G.C.S., Pell J.P., Dobbie R. Interpregnancy interval and risk of pre-term birth and neonatal death: retrospective cohort study. BMJ. 2003;327:313-316.

10 Duncombe D., Skouteris H., Eleanor H., et al. Vigorous exercise and birth outcomes in a sample of recreational exercisers: A prospective study across pregnancy. ANZ J Obstet Gynaecol. 2006;46:288-292.

11 Kramer M.S., McDonald S.W. Aerobic exercise for women during pregnancy. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD000180. doi: 10.1002/14651858.CD000180.pub2

12 Hansen C., Neller A., Williams G., et al. Maternal exposure to low levels of ambient air pollution and pre-term birth in Brisbane, Australia. BJOG. 2006;113:935-941.

13 McCowan Lesley M.E., Dekker Gustaaf A., Chan Eliza, et al. Spontaneous pre-term birth and small for gestational age infants in women who stop smoking early in pregnancy: prospective cohort study. Published 26 March 2009, doi:10.1136/bmj.b1081. Cite this as: BMJ. 2009;338:b1081.

14 McDonald S.D., Perkins S.L., Jodouin C.A., et al. Folate levels in pregnant women who smoke: an important gene/environment interaction. Am J Obstet Gynecol. 2002 Sep;187(3):620-625. PubMed PMID: 12237638

15 Linnet K.M., Wisborg K., Obel C., et al. Smoking during pregnancy and the risk for hyperkinetic disorder in offspring. Pediatrics. 2005 Aug;116(2):462-467.

16 Elliott E.J., Bower C.. Alcohol and pregnancy: the pivotal role of the obstetrician. Aust NZ J Obstet Gynecol. 2008;48:236-239. Online. Avaialble: www.nhmrc.gov.au/guidelines/_files/draft_australian_alcohol_guidelines.pdf (accessed April 2010)

17 Henderson J., Gray R., Brocklehurst P. Systematic review of effects of low/moderate prenatal alcohol exposure on pregnancy outcome. BJOG. 2007;114:243-252.

18 O’Leary C.M., Nassar N., Kurinczuk J.J., et al. The effect of maternal alcohol consumption on fetal growth and pre-term birth. BJOG. 2009;116:390-400.

19 Mengel M.B., Searight H.R., Cook K. Clinical review preventing alcohol/exposed pregnancies. Amer Board Fam Med. 2006;19:494-505.

20 Summers Brooke L., Rofe Allan M. Peter Coyle Dietary Zinc Supplementation Throughout Pregnancy Protects Against Fetal Dysmorphology and Improves Postnatal Survival After Prenatal Ethanol Exposure in Mice. Alcoholism: Clinical and Experimental Research. Published Online: Jan 12 2009. doi: 10.1111/j.1530–0277.2008.00873.x

21 Thorsdottir I., Torfadottir J.E., Birgisdottir B.E., et al. Weight gain in women of normal weight before pregnancy: complications in pregnancy or delivery and birth outcome. Obstet Gynecol. 2002;99:799-806.

22 Asbee Shelly M., Jenkins Todd R., Butler Jennifer R., et al. Preventing Excessive Weight Gain During Pregnancy Through Dietary and Lifestyle Counseling: A Randomised Controlled Trial. Obstetrics and Gynecology. 2009 February;113(2-1):305-312. doi: 10.1097/AOG.0b013e318195baef

23 Cedergren M.I. Maternal morbid obesity and the risk of adverse pregnancy outcome. Obstet Gynecol. 2004;103:219-224.

24 Vahratian A., et al. Maternal prepregnancy overweight and obesity and the patter of labour progression in term nulliparous women. Obstet Gynecol. 2004;104:943-951.

25 van der Steeg J.W., Steures P., Eijkemans M.J., et al. Obesity affects spontaneous pregnancy chances in subfertile, ovulatory women. Hum Reprod. 2008 Feb;23(2):324-328.

26 Leddy M.A., Power M.L., Schulkin J. The impact of maternal obesity on maternal and fetal health. Rev Obstet Gynacol. 2008;1:170-178.

27 Nohr E.A., Bech B.H., Davies M.J., et al. Prepregnancy Obesity and Fetal Death: A Study Within the Danish National Birth Cohort. Obstet Gynecol. 2005;106:250-259.

28 Vujkovic M., Steegers E.A., Looman C.W., et al. The maternal Mediterranean dietary pattern is associated with a reduced risk of spina bifida in the offspring. British Journal of Obstetrics and Gynecology. 2009;116(3):408-415.

29 Marijana Vujkovic, Ocke Marga C., van der Spek Peter J., et al. Maternal Western Dietary Patterns and the Risk of Developing a Cleft Lip With or Without a Cleft Palate. Obstetrics and Gynecology. August 2007;110:378-384. © 2007 by The American College of Obstetricians and Gynecologists

30 Woods R.K., Thien F.C., Abramson M.J. Dietary marine fatty acids (fish oil) for asthma. Cochrane Database Syst Rev. (4):2000. CD001283

31 Dunstan J.A., Mori T.A., Barden A., et al. Fish oil supplementation in pregnancy modifies neonatal allergen-specific immune responses and clinical outcomes in infants at high risk of atopy: a randomised, controlled trial. J Allergy Clin Immunol. 2003 Dec;112(6):1178-1184.

32 Myers G.J., Davidson P.W., Strain J.J. Nutrient and methyl mercury exposure from consuming fish. J Nutr. 2007;137(12):2805-2808.

33 Foods Standards Australia New Zealand. Online. Available: www.foodstandards.gov.au/foodmatters/mercuryinfish.cfm (accessed January 2009).

34 Stanton R. Complete Book of Food and Nutrition. Sydney: Simon and Schuster; 2007.

35 Shabert J.K. Krause’s Food and Nutrition and Diet Therapy, 11th edn, Philadelphia: Saunders; 2004:182-213. Chapter 7

36 Royal Australian and New Zealand College of Obstetricians and Gynaecologists (RANZCOG). Online. Available: http://www.ranzcog.edu.au/publications/statements/C-obs25.pdf (accessed February 2009).

37 Williams C., Birch E.E., Emmett P.M., et al. Stereoacuity at age 3.5 y in children born full-term is associated with prenatal and postnatal dietary factors: a report from a population-based cohort study. AJCN. 2001;73(2):316-322.

38 Dunstan J.A., Prescott S.L. Does fish oil supplementation in pregnancy reduce the risk of allergic disease in infants? Curr Opin Allergy Clin Immunol. 2005;5(3):215-221.

39 Auestad N., Scott D.T., Janowsky J.S., et al. Visual, cognitive, and language assessments at 39 months: a follow-up study of children fed formulas containing long-chain polyunsaturated fatty acids to 1 year of age. Pediatrics. 2003;112(3 Pt 1):e177-e183.

40 Helland I.B., Saugstad O.D., Smith L., et al. Similar effects on infants of n-3 and n-6 fatty acids supplementation to pregnant and lactating women. Pediatrics. 2001;108(5):E82.

41 Helland I.B., Smith L., Saarem K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003;111(1):e39-e44.

42 Dunstan J.A., Roper J., Mitoulas L., et al. The effect of supplementation with fish oil during pregnancy on breast milk immunoglobulin A, soluble CD14, cytokine levels and fatty acid composition. Clin Exp Allergy. 2004;34(8):1237-1242.

43 Olsen S.F., Østerdal M.L., Salvig J.D., et al. Fish oil intake compared with olive oil intake in late pregnancy and asthma in the offspring: 16 y of registry-based follow-up from a randomised controlled trial. ALCN. 2008;88(1):167-175.

44 Olsen S.F., Sørensen J.D., Secher N.J., et al. Randomised controlled trial of effect of fish-oil supplementation on pregnancy duration. Lancet. 1992;339(8800):1003-1007.

45 Martinez M. Tissue levels of polyunsaturated fatty acids during early human development. J Pediatr. 1992;120(4 pt 2):S129-S138.

46 Harris W.S., Connor W.E., Lindsey S. Will dietary omega-3 fatty acids change the composition of human milk? AJCN. 1984;40(4):780-785.

47 Helland I.B., Saarem K., Saugstad O.D., et al. Fatty acid composition in maternal milk and plasma during supplementation with cod liver oil. Eur J Clin Nutr. 1998;52(11):839-845.

48 Bakker E.C., Ghys A.J., Kester A.D., et al. Long-chain polyunsaturated fatty acids at birth and cognitive function at 7 y of age. Eur J Clin Nutr. 2003;57(1):89-95.

49 Ghys A., Bakker E., Hornstra G., et al. Red blood cell and plasma phospholipid arachidonic and docosahexaenoic acid levels at birth and cognitive development at 4 years of age. Early Hum Dev. 2002;69(1–2):83-90.

50 Innis S.M., Gilley J., Werker J. Are human milk long-chain polyunsaturated fatty acids related to visual and neural development in breast-fed term infants? J Pediatr. 2001;139(4):532-538.

51 Smuts C.M., Huang M., Mundy D., et al. A randomised trial of docosahexaenoic acid supplementation during the third trimester of pregnancy. Obstet Gynecol. 2003;101(3):469-479.

52 Malcolm C.A., McCulloch D.L., Montgomery C., et al. Maternal docosahexaenoic acid supplementation during pregnancy and visual evoked potential development in term infants: a double blind, prospective, randomised trial. Arch Dis Child Fetal Neonatal Ed. 2003;88(5):F383-F390.

53 Colombo J., Kannass K.N., Shaddy D.J., et al. Maternal DHA and the development of attention in infancy and toddlerhood. Child Dev. 2004;75(4):1254-1267.

54 Lauritzen L., Jorgensen M.H., Olsen S.F., et al. Maternal fish oil supplementation in lactation: effect on developmental outcome in breast-fed infants. Reprod Nutr De. 2005;45(5):535-547.

55 Jensen C.L., Voigt R.G., Prager T.C., et al. Effects of maternal docosahexaenoic acid intake on visual function and neurodevelopment in breastfed term infants. AJCN. 2005;82(1):125-132.

56 Dunstan J.A., Simmer K., Dixon G., et al. Cognitive assessment at 2(1/2) years after fish oil supplementation in pregnancy: a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2008;93(1):F45-F50.

57 Helland I.B., Smith L., Saarem K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 111(1), 2003.

58 Innis S.M., Friessen R.W. Essential n-3 fatty acids inpregnant women and early visual acuity maturation in term infants. Am J Clin Nutr. 2008;87(3):548-557.

59 Eilander A., Hundscheid D.C., Osendarp S.J., et al. Effects of n-3 long chain polyunsaturated fatty acid supplementation on visual and cognitive development throughout childhood: a review of human studies. Prostaglandins Leukot Essent Fatty Acids. 2007;76(4):189-203.

60 Decsi T., Koletzko B. N-3 fatty acids and pregnancy outcomes. Curr Opin Clin Nutr Metab Care. 2005;8(2):161-166.

61 Helland I.B., Smith L., Blomén B., et al. Effect of supplementing pregnant and lactating mothers with n-3 very-long-chain fatty acids on children’s IQ and body mass index at 7 years of age. Pediatrics. 2008;122(2):e472-e479.

62 Haider B.A., Bhutta Z.A. Multiple micronutrient supplementation for women during pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2006. Art. No.: CD004905. doi: 10.1002/14651858.CD004905.pub2

63 Goh Y.I., Bollano E., Einarson T.R., et al. Prenatal multivitamin supplementation and rates of pediatric cancers: a meta–analysis. Clin Pharmacol Ther. 2007;81:685-691.

64 van den Broek N., Kulier R., Gülmezoglu A.M., et al. Vitamin A supplementation during pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2002. Art. No.: CD001996. doi: 10.1002/14651858.CD001996

65 Rumbold A., Crowther C.A. Vitamin C supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 1):2005. Art. No.: CD004072. doi: 10.1002/14651858.CD004072.pub2

66 Hollis B.W., Wagner C.L. Editorial. Vitamin D deficiency during pregnancy: an ongoing epidemic. AJCN. 2006;84:273.

67 Van der Meer I.M., Karamali N.S., Boeke J.P., et al. High prevalence of vitamin D deficiency in pregnant non-Western women in the Hague, Netherlands. Am J Clin Nutr. 2006;84:350-353.

68 Munns C., Zacharin M.R., et al. Prevention and treatment of infant and childhood vitamin D deficiency in Australia and New Zealand: a consensus statement. MJA. 2006;185:268-272.

69 Weisber P., Kelley S.S., Ruowei Li, et al. Nutritional rickets among children in the United States:review of cases reported between 1986–2003. Am J Clin Nutr. 2004;80(suppl):1697S-1705S.

70 Pettifor J.M. Nutritional rickets: deficiency of vitamin D, calcium, or both? Am J Clin Nutr. 2004;80(suppl):1725S-1729S.

71 Nozza J.M., Rodda C.P. Vitamin D deficiency in mothers of infants with rickets. MJA. 2001;175:253-255.

72 Mahomed K., Gulmezoglu A.M. Vitamin D supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 1):1999. Art. No.: CD000228. doi: 10.1002/14651858.CD000228

73 Wen S.W., Chen X.K., Rodger M., et al. Folic acid supplementation in early second trimester and the risk of preeclampsia. Am J Obstet Gynecol. 2008;198(1):45.e1-45.e7.

74 Mills G.L., Johansson A., Nordmark A., et al. Plasma foalte levels and risk of spontaneous abortion. JAMA. 2002;288:1867-1873.

75 Hernández-Díaz S., Werler M.M., Walker A.M., et al. Folic acid antagonists during pregnancy and the risk of birth defects. NEJM. 2000;343:1608-1614.

76 Krapels I.P., van Rooij I.A., Ocké M.C., et al. Maternal dietary B vitamin intake, other than folate, and the association with orofacial cleft in the offspring. Eur J Nutr. 2004;43(1):7-14. Epub 2004 Jan 6

77 Krapels I.P., van Rooij I.A., Ocké M.C., et al. Maternal nutritional status and the risk for orofacial cleft offspring in humans. Nutr. 2004;134(11):3106-3113.

78 Lumley J., Watson L., Watson M., et al. Periconceptional supplementation with folate and/or multivitamins for preventing neural tube defects. Cochrane Database of Systematic Reviews. (Issue 3):2001. Art. No.: CD001056. doi: 10.1002/14651858.CD001056

79 Wen S.W., Zhou J., Yang Q., et al. Maternal exposure to folic acid antagonists and placenta-mediated adverse pregnancy outcomes. CMAJ. 2009;179:1263-1268.

80 Wen S.W., Walker M. Risk of fetal exposure to folic acid antagonists. J Obstet Gynaecol Can. 2004;26:475-480.

81 Lagrange A.H. Folic acid supplementation for women with epilepsy who might become pregnant nature clinical practice neurology. Nature Clinical Practice Neurology. 2009;5(1):16-17.

82 Vajda F.J., O’Brien T.J., Hitchcock A., et al. Critical relationship between sodium valproate dose and human teratogenicity: results of the Australian register of anti-epileptic drugs in pregnancy. J Clin Neurosci. 2004 Nov;11(8):854-883.

83 Whitehall J., Smith J. Valproate and babies. Aust NZ J Psychiatry. 2008;42:837.

84 Chavarro J.E., Rich-Edwards J.W., et al. Iron intake and risk of ovulatory infertility. Obstet Gynecol. 2006;108:1145-1152.

85 Lozoff B., De Andraca I., Castillo M., et al. Behavioural and developmental effects of preventing iron-deficiency anemia in healthy full-term infants. Pediatrics. 2003;112(4):846-854.

86 Eden A.N. Iron deficiency and impaired cognition in toddlers: an underestimated and undertreated problem. Paediatr Drugs. 2005;7(6):347-352.

87 Peña-Rosas J.P., Viteri F.E. Effects of routine oral iron supplementation with or without folic acid for women during pregnancy. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD004736. doi: 10.1002/14651858.CD004736.pub2

88 Favier M., Hininger-Favier I. Zinc and pregnancy. Gynecol Obstet Fertil. 2005;33(4):253-258.

89 Merialdi M., et al. Randomised controlled trial of prenatal zinc supplementation and fetal bone growth. AJCN. 2004;79:826-830.

90 Fawzi W.W., Villamor E., Msamanga G.I., et al. Improves infant mortality, birth weight and duration of pregnancy in HIV mums:Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr. 2005;81:161-167.

91 Mahomed K., Bhutta Z., Middleton P. Zinc supplementation for improving pregnancy and infant outcome. Cochrane Database of Systematic Reviews. (Issue 2):2007. Art. No.: CD000230. doi: 10.1002/14651858.CD000230.pub3

92 Osendarp S.J., van Raaij J.M., Darmstadt G.L., et al. Zinc supplementation during pregnancy and effects on growth and morbidity in low birth weight infants: a randomised placebo controlled trial. Lancet. 2001;357:1080-1085.

93 Travers C.A., et al. Iodine status in pregnant women and their newborns: are our babies at risk of iodine deficiency? MJA. 2006;184:617-620.

94 Gunton J.E., Hams G., Fiegert M., et al. Iodine deficiency in ambulatory participants at a Sydney teaching hospital: is Australia truly iodine replete. MJA. 1999;171(9):467-470.

95 Glinoer D. Feto-maternal repercussions of iodine deficiency in pregnancy. Ann Endocrinol. 2003;64(1):37-44.

96 Xue-Yi C., Jiang X.M., Dou Z.H., et al. Timing of vulnerability of the brain to iodine deficiency in endemic cretinism. NEJM. 1994;331(26):1739-1744.

97 Kozhimannil K.B., Pereira M.A., Harlow B.L. Association between diabetes and perinatal depression among low-income mothers. JAMA. 2009 Feb 25;301(8):842-847.

98 Zhang C., Solomon C.G., Manson J.E., et al. A prospective study of pregravid physical activity and sedentary behaviours in relation to the risk for gestational diabetes mellitus. Arch Intern Med. 2006 Mar 13;166(5):543-548.

99 Moses Robert G, Barker Megan, Winter Meagan, et al. Gestational diabetes; can a low glycemic index diet reduce the need for insulin? A randomised trial. Diabetes Care Publish Ahead of Print published online ahead of print March 11, 2009. doi: 10.2337/dc09–0007.

100 Tieu J., Crowther C.A., Middleton P. Dietary advice in pregnancy for preventing gestational diabetes mellitus. Cochrane Database of Systematic Reviews. (Issue 2):2008. Art. No.: CD006674. doi: 10.1002/14651858.CD006674.pub2

101 Ray J.G., Vermeulen M.J., Shapiro J.L., et al. Maternal and neonatal outcomes in pregestational and gestational diabetes mellitus, and the influence of maternal obesity and weight gain: the DEPOSIT study. Diabetes Endocrine Pregnancy Outcome Study in Toronto. QJM. 2001;94:347-356.

102 Hamano T. Women with a history of preeclampsia should be monitored for the onset and progression of chronic kidney disease. J Nutr. 2007;137:2805-2808.

103 Marcoux S., Bérubé S., Brisson C., et al. Job strain and pregnancy-induced hypertension. Epidemiology. 1999;10:376-382.

104 Walker S.P., Permezel M., Brennecke S.P., et al. Blood pressure in late pregnancy and work outside the home. Obstetrics and Gynecology. 2001;97:361-365.

105 Qui C., Coughlin K.B., Frederick I.O., et al. Dietary fibre intake in early pregnancy and risk of subsequent preeclampsia. Am JHypertension. 2008;21:903-909.

106. Duley L., Henderson-Smart D., Meher S. Altered dietary salt for preventing pre-eclampsia, and its complications. Cochrane Database of Systematic Reviews. (Issue 4):2005. Art. No.: CD005548. doi: 10.1002/14651858.CD005548

107 Rumbold A., Duley L., Crowther C.A., et al. Antioxidants for preventing pre-eclampsia. Cochrane Database of Systematic Reviews. (Issue 1):2008. Art. No.: CD004227. doi: 10.1002/14651858.CD004227.pub3

108 Rumbold A., Middleton P., Crowther C.A. Vitamin supplementation for preventing miscarriage. (Issue 2):2005. Cochrane Database of Systematic ReviewsArt. No.: CD004073. doi: 10.1002/14651858.CD004073.pub2

109 Rumbold A., Crowther C.A. Vitamin E supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2005. Art. No.: CD004069. doi: 10.1002/14651858.CD004069.pub2

110 Chappell Lucy C., Seed Paul T., Briley Annette L., et al. Effect of Antioxidants on the Occurrence of Pre-Eclampsia in Women at Increased Risk: A Randomised Trial. Obstetrical Gynecological Survey. 2000;55:129-130.

111 Chappell Lucy C., Seed Paul T., et al. Vitamin C and E supplementation in women at risk of preeclampsia is associated with changes in indices of oxidative stress and placental function. Am J Obstet Gynecol. 2002;187:777-784.

112 Beazley D., Ahokas R., Livingston J., et al. Vitamin C and E supplementation in women at high risk for preeclampsia: A double-blind, placebo-controlled trial. American Journal of Obstetrics and Gynecology. 2002;192:520-521.

113 Poston L., Briley A.L., Seed P.T., et al. Vitamin C and vitamin E in pregnant women at risk for pre-eclampsia (VIP trial): randomised placebo-controlled trial. Lancet. 2006;367:1145-1154.

114 Smedts H.P.M., de Vries J.H., Rakhshandehroo M., et al. High maternal vitamin E intake by diet or supplements is associated with congenital heart defects in the offspring. British Journal of Obstetrics and Gynaecology. 2009;16(3):416-423.

115 Villar J., Merialdi M., Gulmezoglu A.M. Nutritional interventions during pregnancy for the prevention or treatment of maternal morbidity and pre-term delivery: An overview of randomised controlled trials. J Nutr. 2003;133:1606S-1625S.

116 Kumar A., Shukla D.K., et al. Calcium supplementation for the prevention of pre-eclampsia. Int J Gynaecol Obstet. 2008;104(1):32-36.

117 Villar J., Abdel-Aleem H., Merialdi M., et al. World Health Organization randomised trial of calcium supplementation among low calcium intake pregnant women. Am J Obstet Gynecol. 2006;194:639-649.

118 Hofmeyr G.J., Atallah A.N., Duley L. Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD001059. doi: 10.1002/14651858.CD001059.pub2

119 Makrides M., Crowther C.A. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2001. Art. No.: CD000937. doi: 10.1002/14651858.CD000937

120 Altman D., Carroli G., Duley L., et al. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet. 2002;359:1877-1890.

121 Meher S., Duley L. Garlic for preventing pre-eclampsia and its complications. Cochrane Database of Systematic Reviews. (Issue 3):2006. Art. No.: CD006065. doi: 10.1002/14651858.CD006065

122 Jewell D., Young G. Interventions for nausea and vomiting in early pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD000145. doi: 10.1002/14651858.CD000145

123 Renwick A.G. Toxicology of micronutrients: Adverse effects and uncertainty. J Nutr. 2006;136:493S-501S.

124 Australian Adverse Drug Reactions Bulletin 2008 August;27;(4).

125 Thaver D., Saeed M.A., Bhutta Z.A. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2006. Art. No.: CD000179. doi: 10.1002/14651858.CD000179.pub2

126 Thaver D., Saeed M.A., Bhutta Z.A. Pyridoxine (vitamin B6) supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2006. Art. No.: CD000179. doi: 10.1002/14651858.CD000179.pub2

127 Jewell D., Young G. Interventions for nausea and vomiting in early pregnancy. The Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD000145. doi: 10.1002/14651858.CD000145

128 Barrelli F., Capasso R., et al. Effectiveness and safety of ginger in the treatment of pregnancy-induced nausea and vomiting. Obstet Gynecol. 2005;105(4):849-856.

129 Lee A., Done M.L. Stimulation of the wrist acupuncture point P6 for preventing postoperative nausea and vomiting. Cochrane Database of Systematic Reviews. (Issue 3):2004. Art. No.: CD003281. doi: 10.1002/14651858.CD003281.pub2

130 Pack A.R., Thomson M.E. Effects of topical and systemic folic acid supplementation on gingivitis in pregnancy. J Clin Periodontol. 1980;7:402-414.

131 Dahle L.O., Berg G., Hammar M., et al. The effect of oral magnesium substitution on pregnancy-induced leg cramps. Am J Obstet Gynecol. 1995;173:175-180.

132 Young G.L., Jewell D. Interventions for leg cramps in pregnancy. Cochrane Database Syst Rev. (1):2002. CD000121

133 Hammar M., Larsson L., Tegler L. Calcium treatment of leg cramps in pregnancy. Effect on clinical symptoms and total serum and ionized serum calcium concentrations. Acta Obstet Gynecol Scand. 1981;60:345-347.

134 Dengfeng W., Taixiang W., Lina Hu, et al. Chinese herbal medicines in the treatment of ectopic pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2007. Art. No.: CD006224. doi:10.1002/14651858.CD006224.pub2

135 Maconochie N., Doyle P., Prior S., et al. Risk factors for first trimester miscarriage–results from a UK-population-based case-control study. BJOG. 2007;114(2):170-186.

136 Weng X., Odouli R., Li D.K. Maternal caffeine consumption during pregnancy and the risk of miscarriage: a prospective cohort study. Am J Obstet Gynecol. 2008;198(3):279.e1-279.e8.

137 Rumbold A., Middleton P., Crowther C.A. Vitamin supplementation for preventing miscarriage. Cochrane Database of Systematic Reviews. (Issue 2):2005. Art. No.: CD004073. doi: 10.1002/14651858.CD004073.pub2

138 de la Calle N., Usandizaga R., Sancha M., et al. Homocysteine, folic acid and B-group vitamins in obstetrics and gynaecology. Eur J Obstet Gynecol Reprod Biol. 2003;107(2):125-134.

139 Nelen W.L., Blom H.J., Thomas C.M., et al. Methylenetetrahydrofolate reductase polymorphism affects the change in homocysteine and folate concentrations resulting from low dose folic acid supplementation in women with unexplained recurrent miscarriages. J Nutr. 1998;128(8):1336-1341.

140 Rostami K. Coeliac disease and reproductive disorders: a neglected association. Eur J Obstet Gynecol Reprod Biol. 2001;96(2):146-149.

141 Hetzel B.S. Story of iodine deficiency: an international challenge in nutrition. New York: Oxford University Press; 1989.

142 George L., Mills J.L., Johansson A.L., et al. Plasma folate levels and risk of spontaneous abortion. JAMA. 2002;288:1867-1873.

143 Slama R., Bouyer J., Windham G., et al. Influence of paternal age on the risk of spontaneous abortion. Am J Epidemiol. 2005;161:816-823.

144 Verkleij-Hagoort A.C., de Vries J.H., et al. Dietary intake of B-vitamins in mothers born a child with a congenital heart defect. Eur J Nutr. 2006;45(8):478-486.

145 Smedts H.P., Rakhshandehroo M., Verkleij-Hagoort A.C., et al. Maternal intake of fat, riboflavin and nicotinamide and the risk of having offspring with congenital heart defects. Eur J Nutr. 2008;47(7):357-365.

146 Hobel C., Culhune J. Role of psychosocial and nutritional stress on poor pregnancy outcome. J Nutr. 133, 2003. 1790S–1717S

147 Li D., Liu L., Odouli R. Presence of depressive symptoms during early pregnancy and the risk of pre-term delivery: a prospective cohort study. Hum Reprod. 2009 Jan;24(1):146-153. Epub 2008 Oct 23. PubMed PMID: 18948314

148 DayanCreveuil J., C Herlicoviez M., et al. Role of Anxiety and Depression in the Onset of Spontaneous Pre-term Labour. Am J Epidemiol. 2002;155(4):293-301.

149 Narendran S., Nagarathna R., Narendran V., et al. Swami Vivekananda Yoga Anusandhana Samsthana (sVYASA), Vivekananda Yoga. Research Foundation, Bangalore, India. ‘Efficacy of yoga on pregnancy outcome.J Altern Complement Med. 2005;11(2):237-244.

150 Evenson K.R., Siega-Riz A.M., Savitz D.A., et al. Vigorous Leisure Activity and Pregnancy Outcome. Epidemiology. 2002;13:653-659.

151 Polyzos Nikolaos P., Polyzos Ilias P., Davide Mauri, et al. Effect of periodontal disease treatment during pregnancy on pre-term birth incidence: a metaanalysis of randomised trials. American Journal of Obstetrics and Gynecology. 2009 March:225-232.

152 Marakoglu I., Gursoy U.K., Marakoglu K., et al. Periodontitis as a risk factor for pre-term low birth weight. Yonsei Med J. 2008;49(2):200-203.

153 Pitiphat J., Joshipura K.J., Gillman M.W., et al. Maternal periodontitis and adverse pregnancy outcomes. Community Dent Oral Epidemiol. 2008;36:3-11.

154 Mercer B.M., Merlino A.A., Milluzzi C.J., et al. Small fetal size before 20 weeks’ gestation: associations with maternal tobacco use, early pre-term birth, and low birth weight. Am J Obstet Gynecol. 2008;198(6):673.e1-673.e7.

155 Suzuki K., Tanaka T., Kondo N., et al. Is maternal smoking during early pregnancy a risk factor for all low birth weight infants? J Epidemiol. 2008;18:89-96.

156 Wills R., Coory M.D. Effect of smoking among Indigenous and non-Indigenous mothers on pre-term birth and full-term low birth weight. MJA. 2008;189(9):490-494.

157 Jaddoe V.W.V., Troe E., Hofman A., et al. Active and passive smoking during pregnancy and the risks of low birth weight and pre-term birth: the generation R study. Paed Perinat Epidem. 2008;20:162-171.

158 Leonardi-Bee J., Smyth A., Britton J., et al. Environmental tobacco smoke and fetal health: systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2008;93(5):F351-F361.

159 Kyrklund-Blomberg Nina B. Cnattingius Sven. Pre-term birth and maternal smoking: Risks related to gestational age and onset of delivery. Am J Obstet Gynecol. 1998;179(4):1051-1055.

160 Olsen S.F., Secher N.J. Low consumption of seafood in early pregnancy as a risk factor for pre-term delivery: prospective cohort study. BMJ. 2002;324:447-450.

161 Khoury J., Henriksen T., Christophersen B., et al. Effect of a cholesterol-lowering diet on maternal, cord, and neonatal lipids, and pregnancy outcome: a randomised clinical trial. Am J Obstet Gynecol. 2005;193:1292-1301.

162 Cook Derek G., Peacock Janet L., Colin Feyerabend, et al. Relation of caffeine intake and blood caffeine concentrations during pregnancy to fetal growth: prospective population based study. BMJ. 1996;313:1358-1362.

163 Hammer Bech Bodil, Obel Carsten, et al. Effect of reducing caffeine intake on birth weight and length of gestation: randomised controlled trial. BMJ. 2007;334:409.

164 Clausson B., Granath F., Ekbom A., et al. Effect of caffeine exposure during pregnancy on birth weight and gestational age. Am J Epidemiol. 2002;155:429-436.

165 Bracken M.B., Triche E.W., Belanger K., et al. Association of maternal caffeine consumption with decrements in fetal growth. Am J Epidemiol. 2002;155:429-436.

166 CARE Study Group. Maternal caffeine intake during pregnancy and risk of fetal growth restriction: a large prospective observational study. BMJ. 2008;337:a2332.

167 Wendler C.C., Busovsky-McNeal B., Ghatpande S., et al. Embryonic caffeine exposure induces adverse effects in adulthood. FASEB J. 2008. as doi:10.1096/fj.08–124941

168 Bech B.H., Nohr E.A., Vaeth M., et al. Coffee and fetal death: a cohort study with prospective data. Am J Epidmiol. 2005;162:983-990.

169 McPhee, A. JAMA 2009;301:175–182.

170 Makrides M., Crowther C.A. Magnesium supplementation in pregnancy. Cochrane Database of Systematic Reviews. (Issue 4):2001. Art. No.: CD000937. doi: 10.1002/14651858.CD000937

171 Doyle L.W., Crowther C.A., Middleton P., et al. Magnesium sulphate for women at risk of pre-term birth for neuroprotection of the fetus. Cochrane Database of Systematic Reviews. (Issue 3):2007. Art. No.: CD004661. doi: 10.1002/14651858.CD004661.pub2

172 Nilsen R.M., Vollset S.E., Rasmussen S.A., et al. Folic acid and Multivitamin Supplement Use and Risk of Placental Abruption: A Population-based Registry Study. Am J Epidemiol. 2008. Epub ahead of print

173 Elizabeth K.E., Krishnan V., Zachariah P. Auxologic, biochemical and clinical (ABC) profile of low birth weight babies – a two-year prospective study. Trop Med. 2007;53(6):374-382.

174 Elizabeth K.E., Krishnan V., Vijayakumar T. Umbilical cord blood nutrients in low birth weight babies in relation to birth weight and gestational age. Indian J Med Res. 2008;128(2):128-133.

175 Newman R.B., Goldenberg R.L., Moawad A.H., et al. Occupational fatigue and pre-term premature rupture of membranes. National Institute of Child Health and Human Development Maternal-Fetal Medicine, Units Network. Am J Obstet Gynecol. 2001 Feb;184(3):438-446.

176 Siega-Riz A.M., Herrmann T.S., Savitz D.A., et al. Frequency of eating during pregnancy and its effect on pre-term delivery. Am J Epidemiol. 2001;153:647-652.

177 Siega-Riz A.M., Promislow J.H., Savitz D.A., et al. Vitamin C and the risk of pre-term delivery. Am J Obstet Gynecol. 2003;189(2):519-525.

178 Casanueva E., Ripoll C., Tolentoin M., et al. Vitamin C supplementation to prevent premature rupture of the chorioamnionic membranes: a randomised trial. ACJN. 2005;81:859-864.

179 Woods J.R.Jr., Plessinger M.A., Miller R.K. Vitamins C and E: missing links in preventing pre-term premature rupture of membranes? Am J Obstet Gynecol. 2001 Jul;185(1):5-10.

180 Olsen S.F., Secher N.J., Tabor A., et al. Randomised clinical trials of fish oil supplementation in high risk pregnancies. Fish Oil Trials In Pregnancy (FOTIP) Team. BJOG. 2000;107:382-395.

181 Othman M., Neilson J.P., Alfirevic Z. Probiotics for preventing pre-term labour. Cochrane Database of Systematic Reviews. (Issue 1):2007. Art. No.: CD005941. doi: 10.1002/14651858.CD005941.pub2

182 AlFaleh K.M., Bassler D. Probiotics for prevention of necrotizing enterocolitis in pre-term infants. Cochrane Database of Systematic Reviews. (Issue 1):2008. Art. No.: CD005496. doi: 10.1002/14651858.CD005496.pub2

183 Pennick V., Young G. Interventions for preventing and treating pelvic and back pain in pregnancy. Cochrane Database of Systematic Reviews. (Issue 2):2007. Art. No.: CD001139. doi: 10.1002/14651858.CD001139.pub2

184 Carolyn E., Manheimer E., Pirotta M., White A. Acupuncture for pelvic and back pain in pregnancy: a systematic review. American Journal of Obstetrics and Gynecology. 2008;March:254-259.

185 Waldenström U., Hildingsson I., Ryding E.L. Antenatal fear of childbirth and its association with subsequent caesarean section and experience of childbirth. BJOG. 2006;113:638-646.

186 Anim-Somuah M., Smyth R., Howell C. Epidural versus non-epidural or no analgesia in labour. Cochrane Database of Systematic Reviews. (Issue 4):2005. Art. No.: CD000331. doi: 10.1002/14651858.CD000331.pub2

187 Cepeda M.S., Carr D.B., Lau J., et al. Music for pain relief. Cochrane Database of Systematic Reviews. (Issue 2):2006. Art. No.: CD004843. doi:10.1002/14651858.CD004843.pub2

188 Chuntharapat S., Petpichetchian W., Hatthakit U. Yoga during pregnancy: effects on maternal comfort, labour pain and birth outcomes. Complement Ther Clin Pract. 2008;14:105-115.

189 Narendran S., Nagarathna R., Narendran V., et al. Efficacy of yoga on pregnancy outcome. J Altern Complement Med. 2005;11:237-244.

190 Chuntharapat S., Petpichetchian W., Hatthakit U. Yoga during pregnancy: effects on maternal comfort, labour pain and birth outcomes. Complement Ther Clin Pract. 2008;14:105-115.

191 Narendran S., Nagarathna R., Narendran V., et al. Efficacy of yoga on pregnancy outcome. J Altern Complement Med. 2005;11:237-244.

192 Smith C.A., Collins C.T., Cyna A.M., et al. Complementary and alternative therapies for pain management in labour. Cochrane Database of Systematic Reviews. (Issue 4):2006. Art. No.: CD003521. doi: 10.1002/14651858.CD003521.pub2

193 Cluett E.R., Nikodem V.C., McCandlish R.E., et al. Immersion in water in pregnancy, labour and birth. Cochrane Database of Systematic Reviews. (Issue 2):2002. Art. No.: CD000111. doi: 10.1002/14651858.CD000111.pub2

194 Salvesen K.A., Mørkved S. Randomised controlled trial of pelvic floor muscle training during pregnancy. BMJ. 2004;329:378-380.

195 Smith C.A. Homoeopathy for induction of labour. Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD003399. doi: 10.1002/14651858.CD003399

196 Dahlen H.G., Homer C.S., Cooke M., et al. Perineal outcomes and maternal comfort related to the application of perineal warm packs in the second stage of labour: a randomised controlled trial. Birth. 2007;34(4):282-290.

197 Raynes-Greenow C.H., Roberts C.L., Barratt A., et al. Pregnant women’s preferences and knowledge of term breech management, in an Australian setting. Midwifery. 2004;20:181-187.

198 Coyle M.E., Smith C.A., Peat B. Cephalic version by moxibustion for breech presentation. Cochrane Database of Systematic Reviews. (Issue 2):2005. Art. No.: CD003928. doi: 10.1002/14651858.CD003928.pub2

199 Beckmann M.M., Garrett A.J. Antenatal perineal massage for reducing perineal trauma. Cochrane Database of Systematic Reviews. (Issue 1):2006. Art. No.: CD005123. doi: 10.1002/14651858.CD005123.pub2

200 East C.E., Begg L., Henshall N.E., et al. Local cooling for relieving pain from perineal trauma sustained during childbirth. Cochrane Database of Systematic Reviews. (Issue 4):2007. Art. No.: CD006304. doi: 10.1002/14651858.CD006304.pub2

201 Hay-Smith J. Therapeutic ultrasound for post-partum perineal pain and dyspareunia. Cochrane Database of Systematic Reviews. (Issue 3):1998. Art. No.: CD000495. doi: 10.1002/14651858.CD000495

202 Dennis C.L., Allen K. Interventions (other than pharmacological, psychosocial or psychological) for treating antenatal depression. Cochrane Database of Systematic Reviews. (Issue 4):2008. Art. No.: CD006795. doi: 10.1002/14651858.CD006795.pub2

203 Dennis C.L. Review: Psychosocial and psychological interventions reduce post-partum depressive symptoms. Evidence-Based Mental Health. 2008;11:79.

204 Morrell C.J., Slade P., Warner R., et al. Clinical effectiveness of health visitor training in psychologically informed approaches for depression in postnatal women: pragmatic cluster randomised trial in primary care. BMJ. 2009;338:a3045.

205 Cornish A.M., McMahon C.A., Ungerer J.A., et al. Postnatal depression and infant cognitive and motor development in the second postnatal year: The impact of depression chronicity and infant gender. Infant Behav Dev. 2005;28:407-417.

206 Cowley D. Antidepressants in Pregnancy: The Ongoing Story. Journal Watch Psychiatry December 29, 2006. http://psychiatry.jwatch.org/cgi/content/full/2006/1229/4 (accessed February 2009).

207 ACOG Committee on Obstetric Practice. ACOG Committee Opinion No. 354: Treatment with selective serotonin reuptake inhibitors during pregnancy. Obstet Gynecol. 2006;108:1601-1603.

208 Levinson-Castiel R., Merlob P., Linder N., et al. Neonatal abstinence syndrome after in utero exposure to selective serotonin reuptake inhibitors in term infants. Arch Pediatr Adolesc Med. 2006;160:173-176.

209 Chun-Fai-Chan B., Koren G., Fayez I., et al. Pregnancy outcome of women exposed to bupropion during pregnancy: a prospective comparative study. Am J Obstet Gynecol. 2005;192:932-936.

210 Hiscock H., Wake M. Infant sleep problems and postnatal depression: a community-based study. Pediatrics. 2001;107(6):1317-1322.

211 Hiscock H., Wake M. Randomised controlled trial of behavioural infant sleep intervention to improve infant sleep and maternal mood. BMJ. 2002;324(7345):1062-1065.

212 Hiscock H., Bayer J.K., Hampton A., et al. Long-term mother and child mental health effects of a population-based infant sleep intervention: cluster-randomised, controlled trial. Pediatrics. 2008;122(3):e621-e627.

213 Freeman M.P., et al. Randomised dose-ranging pilot trial of omega-3 fatty acids for post-partum depression. Acta Psychiatr Scand. 2006;113(1):31-35.

214 M. Freeman. Complementary and alternative medicine for perinatal depression. Journal of Affective Disorders 112(1):1–10.

215 Allen L. Multiple micronutrients in pregnancy and lactation: an overview. AJCN. 2005;81:1206s-1212s.

216 Strandberg T.E., Anderson S., Järvenpää A.L., McKeigue P.M. Premature birth and liquorice consumption during pregnancy. American Journal Epidemiology. 2002;156(9):803-805.

217 Gallo M., et al. Pregnancy outcome following gestational exposure to echinacea: a prospective controlled study. Arch Intern Med. 2000;160:3141-3143.

218 Medicines Control Agency Report. Online. Available: http://www.mhra.gov.uk/index.htm (accessed February 2009).

219 Järvenpää A.L., Vanhanen H., McKeigue P.M. Birth Outcome in Relation to Licorice Consumption during Pregnancy. Am J Epidemiol. 2001;153:1085-1088.

220 Strandberg T.E., Andersson S., Järvenpää A.L., et al. Pre-term Birth and Licorice Consumption during Pregnancy. Am J Epidemiol. 2002;156:803-805.

221 Hughes J., Sellick S., King R., et al. Pre-termbirth and licorice consumption during pregnancy. Am J Epidemiol. 2003;158:190-194.

222 Angelsen N.K., Vik T., Jacobsen G., et al. Breast feeding and cognitive development at age 1 and 5 years. Arch Dis Child. 2001;85(3):183-188.

223 Anderson J.W., Johnstone B.M., Remley D.T. Breast-feeding and cognitive development: a meta-analysis. AJCN. 1999;70(4):525-535.

224 Kramer M.S., Aboud F., Mironova E., et al. Breastfeeding and child cognitive development: new evidence from a large randomised trial. Arch Gen Psychiatry. 2008;65(5):578-584.

225 Helland I.B., Smith L., Saarem K., et al. Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children’s IQ at 4 years of age. Pediatrics. 2003;111(1):e39-e44.

226 Gustafsson P.A., Duchen K., Birberg U., et al. Breastfeeding, very long polyunsaturated fatty acids (PUFA) and IQ at 6 1/2 years of age. Acta Paediatr. 2004;93(10):1280-1287.

227 Lauritzen L., Hoppe C., Straarup E.M., et al. Maternal fish oil supplementation in lactation and growth during the first 2.5 years of life. Pediatr Res. 2005;58(2):235-242.

228 Van der Wijden C., Brown J., Kleijnen J. Lactational amenorrhea for family planning. Cochrane Database of Systematic Reviews. (Issue 4):2003. Art. No.: CD001329. doi: 10.1002/14651858.CD001329. Online. Available: www.cochrane.org/reviews/en/ab001329.html (accessed January 2009)